2nd Quarter - Report

FORBES-TATE for EMERGENT BIOSOLUTIONS

Firm
Client
Income
$40,000
Expenses
—

What was lobbied

4 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

H.R. 6074 - Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020 (Public Law 116-123), H.R. 748 - CARES Act (Public Law 116-136), and FY 2021 Appropriations related to development, acquisition, and stockpiling of medical countermeasures for the U.S. Government; NDAA, provisions related to biological and chemical defense; Issues related to Priority Review Voucher programs; Issues regarding opioid and heroin addiction legislation, naloxone access, co-prescribing, and opioid prescribing guidelines; Emergency Support for Substance Use Disorders Act/Legislation to create emergency grants for states and community-based organizations that serve individuals with substance use disorder; Health and Economic Recovery Omnibus Emergency Solutions Act (HEROES Act), FY 2021 and Covid-19 next supplemental provisions related to development, acquisition, and stockpiling of medical countermeasures for the U.S. Government; Issues related to State Opioid Response Grants funding for FY 2021.

Contacted: Office of Management & Budget (OMB); HOUSE OF REPRESENTATIVES; Office of Natl Drug Control Policy (NDCP); SENATE; Health & Human Services, Dept of (HHS); Centers For Disease Control & Prevention (CDC); Substance Abuse & Mental Health Services Administration (SAMHSA); Justice, Dept of (DOJ)

Bills named: H.R. 6074 (116th), H.R. 748 (116th)

Budget/Appropriations BUD

H.R. 6074 - Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020 (Public Law 116-123), H.R. 748 - CARES Act (Public Law 116-136), and FY 2021 Appropriations related to development, acquisition, and stockpiling of medical countermeasures for the U.S. Government; NDAA, provisions related to biological and chemical defense; Issues related to Priority Review Voucher programs; Issues regarding opioid and heroin addiction legislation, naloxone access, co-prescribing, and opioid prescribing guidelines; Emergency Support for Substance Use Disorders Act/Legislation to create emergency grants for states and community-based organizations that serve individuals with substance use disorder; Health and Economic Recovery Omnibus Emergency Solutions Act (HEROES Act), FY 2021 and Covid-19 next supplemental provisions related to development, acquisition, and stockpiling of medical countermeasures for the U.S. Government; Issues related to State Opioid Response Grants funding for FY 2021.

Contacted: Centers For Disease Control & Prevention (CDC); Office of Management & Budget (OMB); Office of Natl Drug Control Policy (NDCP); Substance Abuse & Mental Health Services Administration (SAMHSA); Health & Human Services, Dept of (HHS); SENATE; Justice, Dept of (DOJ); HOUSE OF REPRESENTATIVES

Bills named: H.R. 748 (116th), H.R. 6074 (116th)

Homeland Security HOM

H.R. 6074 - Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020 (Public Law 116-123), H.R. 748 - CARES Act (Public Law 116-136), and FY 2021 Appropriations related to development, acquisition, and stockpiling of medical countermeasures for the U.S. Government; NDAA, provisions related to biological and chemical defense; Issues related to Priority Review Voucher programs; Issues regarding opioid and heroin addiction legislation, naloxone access, co-prescribing, and opioid prescribing guidelines; Emergency Support for Substance Use Disorders Act/Legislation to create emergency grants for states and community-based organizations that serve individuals with substance use disorder; Health and Economic Recovery Omnibus Emergency Solutions Act (HEROES Act), FY 2021 and Covid-19 next supplemental provisions related to development, acquisition, and stockpiling of medical countermeasures for the U.S. Government; Issues related to State Opioid Response Grants funding for FY 2021.

Contacted: Office of Natl Drug Control Policy (NDCP); Centers For Disease Control & Prevention (CDC); Substance Abuse & Mental Health Services Administration (SAMHSA); HOUSE OF REPRESENTATIVES; Office of Management & Budget (OMB); Justice, Dept of (DOJ); SENATE; Health & Human Services, Dept of (HHS)

Bills named: H.R. 748 (116th), H.R. 6074 (116th)

Disaster Planning/Emergencies DIS

H.R. 6074 - Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020 (Public Law 116-123), H.R. 748 - CARES Act (Public Law 116-136), and FY 2021 Appropriations related to development, acquisition, and stockpiling of medical countermeasures for the U.S. Government; NDAA, provisions related to biological and chemical defense; Issues related to Priority Review Voucher programs; Issues regarding opioid and heroin addiction legislation, naloxone access, co-prescribing, and opioid prescribing guidelines; Emergency Support for Substance Use Disorders Act/Legislation to create emergency grants for states and community-based organizations that serve individuals with substance use disorder; Health and Economic Recovery Omnibus Emergency Solutions Act (HEROES Act), FY 2021 and Covid-19 next supplemental provisions related to development, acquisition, and stockpiling of medical countermeasures for the U.S. Government; Issues related to State Opioid Response Grants funding for FY 2021.

Contacted: SENATE; Justice, Dept of (DOJ); Substance Abuse & Mental Health Services Administration (SAMHSA); Office of Management & Budget (OMB); Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; Office of Natl Drug Control Policy (NDCP); Centers For Disease Control & Prevention (CDC)

Bills named: H.R. 6074 (116th), H.R. 748 (116th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.